X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Transgene Biotek Ltd.
BSE CODE: 526139   |   NSE CODE: NA   |   ISIN CODE : INE773D01018   |   13-Feb-2026 Hrs IST
BSE NSE
Rs. 2.59
0.1 ( 4.02% )
 
Prev Close ( Rs.)
2.49
Open ( Rs.)
2.80
 
High ( Rs.)
2.80
Low ( Rs.)
2.35
 
Volume
128763
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-0.09  -0.09  -0.79  -1.37  -1.38  
   CEPS(Rs)-0.08  -0.07  -0.14  -0.06  -0.07  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-1.00  -0.91  -0.82  -0.03  0.62  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-430.19  -258.11  -1104.17  -531.84  -307.22  
   EBIT Margin(%)-165.40  -219.63  -9769.69  0.00  -5993.54  
   Pre Tax Margin(%)-259.34  -279.05  0.00  0.00  -6153.44  
   PAT Margin (%)-259.34  -279.05  0.00  0.00  -6153.44  
   Cash Profit Margin (%)-223.59  -239.76  -1917.60  -550.95  -309.70  
Performance Ratios          
   ROA(%)-2.03  -2.02  -17.24  -24.70  -20.09  
   ROE(%)0.00  0.00  0.00  -465.75  -105.59  
   ROCE(%)-6.11  -7.35  -57.47  -73.15  -49.07  
   Asset Turnover(x)0.01  0.01  0.00  0.00  0.00  
   Sales/Fixed Asset(x)0.00  0.00  0.00  0.00  0.00  
   Working Capital/Sales(x)-0.02  -0.02  -0.01  -0.01  -0.01  
Efficiency Ratios          
   Fixed Capital/Sales(x)416.02  458.09  1952.92  1241.19  634.57  
   Receivable days0.00  0.00  0.00  0.00  0.00  
   Inventory Days47.53  52.60  425.35  242.36  63.44  
   Payable days0  0.00  1187.70  -1746.92  1857.70  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-43.55  -109.51  -17.86  -57.27  -66.09  
   Price/Book(x)-3.36  -8.98  -3.04  -138.83  7.44  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)151.97  322.14  580.46  453.93  271.42  
   EV/Core EBITDA(x)-117.21  -178.64  -73.86  -158.33  -181.18  
   EV/EBIT(x)-91.88  -146.68  -5.94  -3.87  -4.53  
   EV/CE(x)5.68  10.61  4.63  3.33  2.88  
   M Cap / Sales97.36  262.57  342.41  315.51  204.68  
Growth Ratio          
   Net Sales Growth(%)10.98  326.32  -36.44  -48.87  4642.12  
   Core EBITDA Growth(%)20.21  2.17  -74.21  2.14  62.89  
   EBIT Growth(%)16.42  90.42  47.08  -0.11  3.96  
   PAT Growth(%)-3.14  89.09  42.25  0.30  4.83  
   EPS Growth(%)-3.11  89.09  42.25  0.30  4.83  
Financial Stability Ratios          
   Total Debt/Equity(x)-1.92  -2.04  -2.11  -60.99  2.43  
   Current Ratio(x)0.10  0.10  0.10  0.08  0.05  
   Quick Ratio(x)0.10  0.10  0.10  0.07  0.04  
   Interest Cover(x)-1.76  -3.70  -8.63  -44.40  -37.48  
   Total Debt/Mcap(x)0.57  0.23  0.70  0.44  0.33